Alpha 2.0
Login Register
» Authors » Giorgio Ciprandi

Giorgio Ciprandi

Explore the profile of Giorgio Ciprandi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 496
Citations 3006
Followers 0
Related Specialties
Allergy & Immunology
Pulmonary Medicine
General Medicine
Top 10 Co-Authors
Maria Angela Tosca
Gian Luigi Marseglia
Amelia Licari
Ignazio Cirillo
Gianluigi Marseglia
Michele Miraglia Del Giudice
Irene Schiavetti
Matteo Gelardi
Mara De Amici
Michela Silvestri
Published In
Acta Biomed
Ann Allergy Asthma Immunol
Allergy Asthma Proc
Allergol Immunopathol (Madr)
Pediatr Allergy Immunol
Affiliations
Soon will be listed here.
Recent Articles
1.
A multicomponent food supplement with quercetin Phytosome®, zinc and vitamin C may be favorable in managing children with seasonal allergic rhinitis: a pilot study
Tosca M, Ferrecchi C, Meleca V, Naso M, Ciprandi G
Minerva Pediatr (Torino) . 2025 Mar; PMID: 40080068
No abstract available.
2.
Ketoprofen and ketoprofen lysine salt in managing children with mild-moderate acute pain: evidence emerging from comparative trials
Ciprandi G, Scaglione F
Panminerva Med . 2025 Mar; PMID: 40071322
Acute pain is a common symptom experienced by all children. Pain may be due to different causes, but inflammatory pain is the most common. In addition, infectious diseases are characterized...
3.
Visual Analog Scale for Asthma and Rhinitis Symptoms: Different Approaches of Measurement
Tosca M, Meleca V, Trincianti C, Naso M, Schiavetti I, Ciprandi G
Pediatr Pulmonol . 2025 Mar; 60(3):e71041. PMID: 40052726
No abstract available.
4.
A multidisciplinary Delphi consensus on budesonide aqueous nasal spray in managing upper respiratory diseases
Ciprandi G, La Mantia I, Varricchio A, Study Group On Topical Nasal Therapy
Multidiscip Respir Med . 2025 Mar; 20. PMID: 40026032
Allergic rhinitis (AR), non-allergic rhinitis (NAR), and chronic rhinosinusitis with nasal polyps (CRSwNP) share a type 2 inflammation. Thus, intranasal corticosteroids (INCS) are recommended for managing these diseases. In this...
5.
Ketoprofen and its lysine salt in managing children with fever: evidence emerging from comparative trials
Scaglione F, Ciprandi G
Panminerva Med . 2025 Feb; PMID: 39964320
Fever usually is a physiological response to infectious/inflammatory acute events. Namely, fever has positive benefits contrasting noxious agents. However, when fever causes discomfort, it is better to relieve symptoms associated...
6.
An intranasal multicomponent medical device (Saflovir®) may represent a valuable option in managing upper airways diseases
Ciprandi G, Drago L, La Mantia I, Tosca M
Minerva Pediatr (Torino) . 2025 Feb; PMID: 39964277
No abstract available.
7.
Survey on the attitude of Italian pediatricians concerning the use of the topical nasal therapy
Ciprandi G, Varricchio A
Minerva Pediatr (Torino) . 2025 Jan; PMID: 39817830
No abstract available.
8.
Relationship between recurrent respiratory infections and allergy: a
Ciprandi G, Tosca M
J Asthma . 2025 Jan; 1-2. PMID: 39751628
No abstract available.
9.
Pidotimod in pediatrics: new evidence and future perspectives
Ciprandi G, Marseglia G
Multidiscip Respir Med . 2024 Dec; 19. PMID: 39665764
Pidotimod is a synthetic dipeptide that exerts immunomodulatory activity, modifying innate and adaptive immunity. Pidotimod firstly acts on Toll-like receptors, then on antigen-presenting cells and other immunocompetent cells. Pidotimod also...
10.
Inter-societal Survey on the topical nasal treatments in Italy
Varricchio A, Presutti L, La Mantia I, Varricchio A, Ciprandi G
Multidiscip Respir Med . 2024 Dec; 19. PMID: 39625393
Topical nasal therapy represents a widespread opportunity to treat upper airway diseases. As a result, specialists in different areas (mainly ENT, pediatrics, and allergology) and general practitioners prescribe intranasal compounds....